3 shares to buy from the 3 hottest ASX sectors right now

Bell Potter's Grady Wulff revealed in Sydney the stocks that her team is keen on at the moment.

| More on:
A portrait of Bell Direct market analyst Grady Wulff

Image source: Bell Direct

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Maybe you are sick of hearing this, but it doesn't make it any less true: it's a turbulent time for ASX shares at the moment.

With much of the world still struggling with both high inflation and steep interest rate rises, it's touch-and-go whether some of the largest economies will fall into recession.

In such a time, Bell Potter market analyst Grady Wulff suggests targeting three specific ASX sectors to buy into: energy, retail and healthcare.

"For energy, there is one specific stock in there that we have a really high outlook on," Wulff said at the Australian Shareholders Association conference this week.

"Investors have fled retail stocks… but there's value in this space when you look for value shopping."

Healthcare has outperformed the market over the last decade, she added, but there are still "quite a few opportunities" right now.

So here are three ASX shares from those industries that Wulff and the Bell Potter team rate as buys:

The three best buys in the three best ASX sectors

From the retail sector, Wulff's team likes the look of Accent Group Ltd (ASX: AX1), which is best known for operating the ubiquitous shoe chain The Athlete's Foot.

The share price has already done pretty well. It's risen 74% over the past five years, a whopping 266% since the COVID-19 market crash, and it has doubled since September.

Wulff told investors to not let that put them off.

"This company continues to go from strength to strength. There's no reason not to consider it for your portfolio."

She noted how sales are still growing year-on-year, even though customers are now grappling with interest rates that are 3.75 percentage points higher.

"The fact that they're able to weather tougher economic conditions says they're up to something really special."

In the health space, Bell Potter's current darling is Telix Pharmaceuticals Ltd (ASX: TLX), which produces cancer diagnostic and treatment products.

The company entered into a revenue-making phase last year after its diagnostic imaging tracer Illucix started selling commercially.

Wulff told the Sydney audience that while diagnostic products bring some money in, the real margins are still coming in the treatment products that are currently jumping through bureaucratic hoops.

"Imaging agents make around US$5,000 revenue… per dose," she said.

"The therapy drug for prostate cancer and kidney cancer is US$250,000 per dose per patient."

So Telix has these potentially massive catalysts coming, all while the diagnostic products are bringing in revenue to keep its research and development running without needing to raise capital.

Telix shares have rocketed 62% year to date.

Wulff's pick in the energy sector is uranium producer Boss Energy Ltd (ASX: BOE).

Uranium prices were at rock bottom over the 2010s after nuclear power generation went out of fashion following the Fukushima disaster.

But Russia's invasion of Ukraine last year and the subsequent global energy crisis have prompted many countries to reactivate their reactors.

"The company's project is the Honeymoon mine, which has been in care-and-maintenance since 2013… because uranium prices have been so low," said Wulff.

"We've now seen the price of uranium come off the low last year."

She recently spoke to the Boss Energy managing director Duncan Craib, who is confident of digging up the nuclear fuel very soon.

"He's very optimistic that they're on track, on time and on budget for first production in December 2023, first sales in 2024, and sales to double by 2025."

The Boss Energy share price has already climbed 35% so far this year.

Motley Fool contributor Tony Yoo has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

A women cheers with clenched fists having read some good news on her laptop.
Dividend Investing

3 excellent ASX dividend shares to buy now

Analysts say that these shares are in the buy zone right now for income investors.

Read more »

Woman relaxing on her phone on her couch, symbolising passive income.
Dividend Investing

Here's how much passive income I'd get if I invested $20,000 in Westpac shares now

A $20,000 investment in Westpac shares could deliver some welcome additional passive income.

Read more »

Three women cruise along enjoying ice-creams in the sunshine.
Dividend Investing

Passive income powerhouses! 3 ASX shares I'd consider buying for rising dividends

Here are three ASX dividend shares that I think are worth considering today.

Read more »

Man waiting for his flight and looking at his phone.
Growth Shares

Near its 52-week low, this ASX growth stock could be the bargain of the year!

I think this stock could be a leading opportunity.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Dividend Investing

Invest $10,000 in this ASX dividend stock for $550 per year in passive income

Big returns and passive income could be on the cards for investors according to Morgans.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

2 top ASX growth shares to buy today and hold for 10 years

Analysts are very bullish on the outlooks of these buy-rated shares.

Read more »

Person handing out $100 notes, symbolising ex-dividend date.
Growth Shares

What are the best ASX shares to buy with $500 in 2024?

Analysts are bullish on these shares for good reason. Let's find out why.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

Buy BHP and these ASX dividend shares

Analysts think these income options would be great picks this month.

Read more »